Aurora Cannabis Inc. (TSE:ACB) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Aurora Cannabis Inc. (TSE:ACB) have received a consensus rating of “Moderate Buy” from the five ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and two have given a strong buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is C$7.11.

Several analysts have recently weighed in on the company. ATB Capital reduced their price target on Aurora Cannabis from C$11.00 to C$8.50 in a report on Tuesday, December 17th. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. Finally, Atb Cap Markets upgraded Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th.

Aurora Cannabis Trading Down 4.9 %

TSE ACB opened at C$8.94 on Friday. Aurora Cannabis has a twelve month low of C$3.84 and a twelve month high of C$12.85. The business’s fifty day moving average is C$6.42 and its 200 day moving average is C$7.22. The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72. The company has a market cap of C$489.09 million, a price-to-earnings ratio of -11.04 and a beta of 2.71.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.